Northwestern Mutual Wealth Management
ACXP icon

Northwestern Mutual Wealth Management’s Acurx Pharmaceuticals ACXP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ACXP Stock Details ACXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-82
Closed -$1.33K – 3652
2024
Q4 		$1.33K Hold
82
– – ﹤0.01% 3254
2024
Q3 		$3.11K Hold
82
– – ﹤0.01% 3025
2024
Q2 		$3.68K Buy
+82
New +$3.6K ﹤0.01% 2954

Other funds holding ACXP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFS
Prospect Financial Services Melville, New York $164M AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCWA
Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northwestern Mutual Wealth Management's ACXP Position: Q1 2025 in Review

Northwestern Mutual Wealth Management sold out of Acurx Pharmaceuticals (ACXP) in Q1 2025, closing a stake of 82 shares — an estimated $1.33K sold.

Northwestern Mutual Wealth Management first reported a position in ACXP in Q2 2024 and held it in 3 quarters. The position peaked at $3.68K in Q2 2024. 24 funds tracked by Wall St. Rank hold ACXP as of Q1 2025.

  • Northwestern Mutual Wealth Management reported no remaining Acurx Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 82 Acurx Pharmaceuticals shares in Q1 2025, an estimated $1.33K.
  • Northwestern Mutual Wealth Management first reported a position in Acurx Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Northwestern Mutual Wealth Management's Acurx Pharmaceuticals position peaked at $3.68K in Q2 2024.
  • 24 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.